Human fibronectin was isolated from second-trimester amniotic fluid, from amniotic fluid obtained at term and from adult plasma. The amniotic-fluid fibronectins had a slightly higher apparent molecular weight on sodium dodecyl sulphate/polyacrylamidegel electrophoresis than the plasma fibronectin. Early-and late-amniotic-fluid fibronectin had 9.5 and 9.6% carbohydrate respectively, whereas plasma fibronectin had 5.8%. The amniotic-fluid fibronectins had similar mannose and sialic acid contents to plasma fibronectin, but greater amounts of glucosamine, galactosamine, galactose and fucose. There were no detectable differences in the amino-acid composition of amniotic-fluid and plasma fibronectins, and the patterns of peptides obtained after tryptic digestion of fibronectin from the two sources showed extensive similarities. Fibronectins from plasma and amniotic fluid were equally active in promoting cell attachment and were immunologically indistinguishable. These results show that fibronectin from amniotic fluid is more heavily glycosylated than plasma fibronectin or previously analysed fibronectins from cultured fibroblasts. The observed differences in glycosylation may be related to cell type and/or stage of development.
Human fibronectin was isolated from second-trimester amniotic fluid, from amniotic fluid obtained at term and from adult plasma. The amniotic-fluid fibronectins had a slightly higher apparent molecular weight on sodium dodecyl sulphate/polyacrylamidegel electrophoresis than the plasma fibronectin. Early-and late-amniotic-fluid fibronectin had 9.5 and 9.6% carbohydrate respectively, whereas plasma fibronectin had 5.8%. The amniotic-fluid fibronectins had similar mannose and sialic acid contents to plasma fibronectin, but greater amounts of glucosamine, galactosamine, galactose and fucose. There were no detectable differences in the amino-acid composition of amniotic-fluid and plasma fibronectins, and the patterns of peptides obtained after tryptic digestion of fibronectin from the two sources showed extensive similarities. Fibronectins from plasma and amniotic fluid were equally active in promoting cell attachment and were immunologically indistinguishable. These results show that fibronectin from amniotic fluid is more heavily glycosylated than plasma fibronectin or previously analysed fibronectins from cultured fibroblasts. The observed differences in glycosylation may be related to cell type and/or stage of development.
Fibronectin, a 450000-mol.wt. glycoprotein, is present in soluble form in plasma of different vertebrate species and in the growth media of cells cultured in vitro. It is found in an insoluble form at the surface of normal cells and in the surrounding extracellular matrix, where it seems to be involved in cell attachment (for references, see Vaheri et al., 1978) . Fibronectin is also present in amniotic fluid (Chen et al., 1976; Crouch et al., 1978; Kuusela et al., 1978) . The amounts present far exceed the concentration that could be expected to reach amniotic fluid from the maternal circulation, the main source of proteins in amniotic fluid. Based on this and the fact that cells cultured from amniotic fluid produced fibronectin, it is assumed that fibronectin in amniotic fluid is produced locally (Chen et al., 1976; Crouch et al., 1978) . A difference in the apparent molecular weights of fibronectin from plasma and amniotic fluid as detected by sodium dodecyl sulphate/polyacrylamide-gel electrophoresis (Crouch et al., 1978) supports this conclusion. Fibronectins obtained from cultured cells have also, in many instances, been found to be slightly larger than the plasma form Vol. 193 (Keski-Oja et al., 1977; Engvall et al., 1978; Yamada & Kennedy, 1979) .
As a step toward clarification of the structural and functional relationship of different fibronectins, we have compared the properties of fibronectin from plasma and amniotic fluid. We show that fibronectins from these sources differ by several criteria most notably by carbohydrate composition, but are immunologically indistinguishable when tested with conventional antisera and are equally active promoters of cell attachment.
Experimental Isolation offibronectin and immunological methods
Pooled adult human citrate plasma and pooled amniotic fluid collected during the second trimester or at term were used as sources of fibronectin. Chromatography on gelatin-Sepharose was used to isolate fibronectin (Engvall & Ruoslahti, 1977 For tryptic digestion, the dry fibronectin was suspended in 0.5 M-NH4HCO3 and digested with 1% (w/w) of diphenylcarbamoylchloride-treated trypsin (Sigma Chemical Co., St. Louis, MO, U.S.A.) for 6 h at 370C. The digests were fractionated on gelatinSepharose and concanavalin A-Sepharose (Pharmacia Fine Chemicals, Piscataway, NJ, U.S.A.) as described previously .
Preparation and properties of the fibronectin antibodies and radioimmunoassay of fibronectin have been described in detail previously . Polyacrylamide-gel electrophoresis in the presence of sodium dodecyl sulphate was carried out as described by Laemmli (1970) . Thyroglobulin (mol.wt. 330000), ferritin (mol.wt. 220000), albumin (mol.wt. 67 000) and catalase (mol.wt. 60000) from Pharmacia and myosin (mol.wt. 200000) from Sigma were used as molecular-weight markers.
Chemical analyses
Neutral sugars were analysed by borate complex anion-exchange chromatography (Spiro et al., 1976) after hydrolysis (1M-HCl for 6h at 100°C) and passage through coupled columns of Dowex 50 and Dowex 1 as previously described (Spiro, 1966) . Amino sugars were resolved on the Technicon NC-2 amino-acid analyser with a program that utilized pH5 buffers (Spiro et al., 1976) after hydrolysis in 4M-HCI at 100°C for 6h. The thiobarbituric acid reaction (Warren, 1959) was employed to determine sialic acids after hydrolysis with 0.1 M-H2SO4 at 800C for 60min. Amino-acid analyses were performed on the Technicon NC-2 amino-acid analyser after hydrolysis of the samples in constant-boiling HCI in sealed tubes under N2 at 1050C for 28h.
Cell-attachment assay To determine the capacity of fibronectin to mediate cell attachment, wells in non-treated polystyrene microtitre plates (Flow Laboratories, Inglewood, CA, U.S.A.) were coated with different amounts of fibronectin. Trypsin-treated normal rat kidney cells in serum-free medium containing 0.5 mg of soya-bean trypsin inhibitor/ml were added to the wells. The plate was washed after 1 h of incubation and attached cells were counted .
Results
Sodium dodecyl sulphate/polyacrylamide-gel electrophoresis analysis showed that fibronectin from amniotic fluid moved as a diffuse band of lower mobility than the doublet band obtained with plasma fibronectin. Fibronectin from amniotic fluid collected during the second trimester and at term gave a similar band. Comparison with standards gave mol.wts. of approx. 220000 and 235000 for the subunits of plasma and amniotic-fluid fibronectins respectively.
It has been established previously that fibronectin from plasma and amniotic fluid are indistinguishable when tested for immunodiffusion against antisera to plasma fibronectin (Kuusela et al., 1978) . Competitive radioimmunoassays were performed by using both '251-labelled fibronectin from plasma and antibodies against plasma fibronectin, and 1251-labelled amniotic-fluid fibronectin and antibodies against the fibronectin from amniotic fluid. Unlabelled fibronectin from the two sources gave identical inhibition curves in the two assays. A representative assay result is shown in Fig. 1 .
When peptides from tryptic digests of fibronectin from plasma and early amniotic fluid were compared on sodium dodecyl sulphate/polyacrylamide-gel electrophoresis, the patterns showed much similarity, but also some slight differences (Fig. 2) . To increase the resolution, the fragments from tryptic digestion of fibronectin isolated from plasma and early amniotic fluid were fractionated on the basis of binding to gelatin-Sepharose and con-FN -1 2 3 4 5 6 7 8 9 10
canavalin A-Sepharose. Both digests showed a prominent band at mol.wt. 30000 in the fraction that was bound to gelatin (Fig. 2, lanes 5 and 6) . This band co-migrated with the mol.wt.-30000 collagenbinding fragment we have described before . The amino-acid analyses obtained were in 
Fig. 2. Polyacrylamide-gel electrophoresis in the presence
of sodium dodecyl sulphate of tryptic digests ofplasma fibronectin (odd-numbered lanes) and of amniotic-fluid fibronectin (even-numbered lanes) Lanes (1) and (2) show total digests; (3) and (4), gelatin-Sepharose-non-binding fractions; (5) and (6), gelatin-bound fractions; (7) and (8), concanavalin A-non-binding fractions; (9) and (10), concanavalin A-bound fractions. The position of fibronectin (FN) (Table 2) . Fibronectin from second trimester as well as that from term amniotic fluid was found to contain more total saccharide than the protein isolated from plasma. Galactose, fucose, glucosamine and galactosamine were all present in larger amounts in fibronectin from amniotic fluid, whereas the quantities of mannose and sialic acid were about the same as in plasma fibronectin.
Comparison of the ability of fibronectin from plasma and amniotic fluid to promote attachment of normal rat kidney cells showed them to be approximately equally active (Fig. 3) .
Discussion
Our results establish some substantial chemical differences between fibronectins from amniotic fluid and plasma. We found that these fibronectins differ in their carbohydrate compositions. The carbohydrate analyses suggest that both plasma and amnioticfluid fibronectins contain the complex-type of asparagine-linked units (Spiro, 1973) , such as have been described in fibronectin from hamster embryo fibroblasts (Fukuda & Hakomori, 1979) and from human (Wrann, 1978) and bovine (Takasaki et al., 1979) plasma. However, the occurrence of larger amounts of galactose and glucosamine as well as substantial quantities of fucose and galactosamine in the amniotic-fluid fibronectin suggests that this protein may contain a second type of saccharide unit, perhaps similar to the newly described heteroglycan of erythrocyte membranes (Krusius et al., 1978) . The additional carbohydrate of amnioticfluid fibronectin would be expected to add approx. 10000 mol.-wt. units to its subunit molecular weight. This is in approximate agreement with the molecular-weight difference we obtained in polyacrylamide-gel electrophoresis. This and the fact that the immunological reactivities and amino-acid compositions of fibronectins from plasma and amniotic fluid were indistinguishable suggests that their polypeptide chains could be identical or very similar.
The differences in the peptide composition of fibronectin from plasma and amniotic fluid after trypsin treatment are seemingly difficult to reconcile with the contention that their polypeptide parts would be identical. However, the differences were minor, and it has been found that non-glycosylated fibronectin from tunicamycin-treated cells is more susceptible to proteolysis than glycosylated fibronectin (Olden et al., 1979) . The additional carbohydrate residues in amniotic-fluid fibronectin could offer protection against proteolysis, resulting in peptide differences. Since this work was completed Alitalo et al. (1980) have reported on a fibronectin from cultured amniotic epithelial cells that migrates more slowly than plasma fibronectin in sodium dodecyl sulphate/polyacrylamide gels. Similar to our results, they found that this fibronectin, which seems to be a counterpart in vitro of fibronectin in amniotic fluid, shares with plasma fibronectin all but one of the peptides generated by digestion with Staphylococcal proteinase.
Since fibronectin from cultures of embryonic fibroblasts has been reported to move on sodium dodecyl sulphate/polyacrylamide-gel electrophoresis with a mobility lower than that of plasma fibronectin (Yamada & Kennedy, 1979; Engvall et al., 1978) , and amniotic-fluid fibronectin shares this characteristic (Crouch et al., 1978) , it has been assumed that amniotic-fluid fibronectin represents a cellular fibronectin distinct from the circulating fibronectin. However, it has been shown previously that fibronectins from plasma and spent culture media of fibroblasts both have about 5% carbohydrate with closely similar compositions (Vuento et al., 1977; Yamada et al., 1977; Wrann, 1978; Fukuda & Hakomori, 1979; Takasaki et al., 1979) . The features that distinguish amniotic-fluid fibronectin from plasma fibronectin, therefore, do not seem to reflect general differences between cellular and circulating fibronectins. Instead, they could be related to the different developmental stage and/or origin of the cell type that synthesizes these fibronectins.
There are other examples of a situation in which the glycosylation of a polypeptide depends on the phenotype and developmental stage of the cell synthesizing it. a-Foetoprotein synthesized by the mouse yolk sac does not bind to concanavalin A, but the same protein, when it originates from the liver, does so (Ruoslahti & Adamson, 1978) . Several membrane proteins carry a larger oligosaccharide moiety when they come from transformed cells than when they come from normal cells (Warren et al., 1978) .
Whether the variations between fibronectins from different sources have functional significance needs to be further explored. It has been reported that fibronectin derived from cultured fibroblasts is more active in altering the morphology of transformed cells toward normal (Yamada & Kennedy, 1979) . We found the plasma and amniotic-fluid forms approximately equally active in our assay for cell attachment. In our hands (E. G. Hayman & E. Ruoslahti, unpublished work), transformed cells have not assumed a normal morphology when treated with either plasma or amniotic-fluid fibronectin, even at concentrations well above those at which plasma fibronectin has been reported to be active. Whether or not fibronectins from different sources differ functionally, they could still provide useful markers for various cell types on the basis of their sugar compositions and/or electrophoretic mobility. We have recently found that fibronectin produced by human teratocarcinomas resembles that of amniotic fluid, suggesting that it could provide' a new oncodevelopmental marker for such tumours (E. Ruoslahti & D. Raghavan, unpublished work).
